Amdocs (NASDAQ:DOX) was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating in a report issued on Tuesday, BidAskClub reports.

A number of other research analysts have also recently commented on the stock. JPMorgan Chase & Co. decreased their target price on shares of Amdocs from $70.00 to $67.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 15th. ValuEngine cut shares of Amdocs from a “hold” rating to a “sell” rating in a research report on Friday, February 15th. TheStreet raised shares of Amdocs from a “c+” rating to a “b-” rating in a research report on Tuesday, June 4th. Finally, Zacks Investment Research raised shares of Amdocs from a “hold” rating to a “buy” rating and set a $68.00 target price on the stock in a research report on Friday, May 17th. Five analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Amdocs has an average rating of “Hold” and an average price target of $71.40.

Shares of DOX stock opened at $61.00 on Tuesday. The stock has a market cap of $8.46 billion, a PE ratio of 16.31, a PEG ratio of 1.78 and a beta of 0.39. Amdocs has a twelve month low of $52.60 and a twelve month high of $70.31.

Amdocs (NASDAQ:DOX) last announced its quarterly earnings results on Tuesday, May 14th. The technology company reported $1.06 earnings per share for the quarter, beating the consensus estimate of $1.03 by $0.03. The firm had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $1.02 billion. Amdocs had a net margin of 8.96% and a return on equity of 15.18%. The company’s revenue was up 2.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.95 EPS. Analysts expect that Amdocs will post 4.01 earnings per share for the current year.

A number of hedge funds and other institutional investors have recently bought and sold shares of DOX. Marshall Wace North America L.P. acquired a new stake in shares of Amdocs during the first quarter worth about $3,839,000. Cerebellum GP LLC lifted its position in shares of Amdocs by 41.0% during the first quarter. Cerebellum GP LLC now owns 6,057 shares of the technology company’s stock worth $328,000 after purchasing an additional 1,762 shares in the last quarter. Nordea Investment Management AB lifted its position in shares of Amdocs by 28.9% during the first quarter. Nordea Investment Management AB now owns 2,867,827 shares of the technology company’s stock worth $155,177,000 after purchasing an additional 643,331 shares in the last quarter. FMR LLC lifted its position in shares of Amdocs by 12.1% during the first quarter. FMR LLC now owns 20,412,323 shares of the technology company’s stock worth $1,104,510,000 after purchasing an additional 2,203,154 shares in the last quarter. Finally, Ladenburg Thalmann Financial Services Inc. increased its stake in shares of Amdocs by 6.5% during the first quarter. Ladenburg Thalmann Financial Services Inc. now owns 7,419 shares of the technology company’s stock worth $401,000 after buying an additional 455 shares during the period. 91.54% of the stock is currently owned by institutional investors.

About Amdocs

Amdocs Limited, through its subsidiaries, provides software and services to the communications, pay TV, entertainment, and media industry service providers worldwide. The company offers amdocsONE a line of services designed for various stages of a service provider's lifecycle, including planning, delivery, implementation, and ongoing support, as well as consumer experience and monetization, media and digital, enterprise and connected society, service-driven network, and services and agile operation solutions.

Featured Story: What is the Moving Average Convergence Divergence (MACD) oscillator?

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.